Does lamotrigine influence valproate concentrations?
- PMID: 12352935
- DOI: 10.1097/00007691-200210000-00009
Does lamotrigine influence valproate concentrations?
Abstract
The aim of this study is to investigate the effect of lamotrigine (LTG) on valproate (VPA) concentrations dependent on LTG dose, LTG concentration, and additional enzyme-inducing antiepileptic drugs (AED) as well. For this purpose the following patient groups were compared: VPA monotherapy, VPA + one enzyme-inducing AED, VPA + LTG, and VPA + LTG + one enzyme-inducing AED. A total of 400 serum concentrations from 372 patients were evaluated. Two or more serum samples from the same patient were considered only if the comedication had been changed. For statistical evaluation, regression analytical methods and an analysis of variance were performed. For the analysis of variance, the VPA serum concentration in relation to VPA dose:body weight (level:dose ratio, LDR) was calculated and compared for different drug combinations. The analysis of variance revealed a significant effect of enzyme-inducing comedication (as expected) and age on the VPA LDR. Patients on LTG had a slightly lower VPA LDR, but this effect was not statistically significant. In addition, nonlinear regression analysis confirmed that patients on enzyme-inducing AED (carbamazepine, phenytoin, phenobarbital, methsuximide) had significantly lower VPA concentrations. Patients on ethosuximide had slightly but not significantly lower VPA concentrations. Patients on LTG also had significantly lower VPA levels, but this effect was only minor (-7%) and most probably not of any clinical relevance. Furthermore, the regression analysis showed that the relationship between the VPA dose per body weight and the serum concentration deviates significantly from linearity. Children less than 6 years old had lower VPA levels than older children and adults on a comparable VPA dose per body weight. Gender had no significant influence on VPA serum concentration. In addition, a subgroup of 40 patients was analyzed to see whether changing the LTG dose influences VPA serum concentrations. It did not. Thus, the authors conclude that the effect of LTG on VPA concentrations is not of clinical relevance.
Similar articles
-
Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.Ther Drug Monit. 1999 Apr;21(2):175-81. doi: 10.1097/00007691-199904000-00007. Ther Drug Monit. 1999. PMID: 10217337
-
Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.Ther Drug Monit. 1996 Oct;18(5):523-31. doi: 10.1097/00007691-199610000-00001. Ther Drug Monit. 1996. PMID: 8885114 Clinical Trial.
-
Effect of comedication on lamotrigine clearance in Korean epilepsy patients.Clin Chim Acta. 2015 Jan 1;438:269-73. doi: 10.1016/j.cca.2014.09.004. Epub 2014 Sep 8. Clin Chim Acta. 2015. PMID: 25218785
-
Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.Neurology. 2004 Sep 28;63(6):1022-6. doi: 10.1212/01.wnl.0000138424.33979.0c. Neurology. 2004. PMID: 15452293 Review.
-
Children versus adults: pharmacokinetic and adverse-effect differences.Epilepsia. 2002;43 Suppl 3:53-9. doi: 10.1046/j.1528-1157.43.s.3.5.x. Epilepsia. 2002. PMID: 12060006 Review.
Cited by
-
Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review.Ther Adv Psychopharmacol. 2021 Oct 8;11:20451253211045870. doi: 10.1177/20451253211045870. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 34646439 Free PMC article. Review.
-
Population pharmacokinetics of lamotrigine in Chinese children with epilepsy.Acta Pharmacol Sin. 2012 Nov;33(11):1417-23. doi: 10.1038/aps.2012.118. Epub 2012 Oct 29. Acta Pharmacol Sin. 2012. PMID: 23103620 Free PMC article.
-
Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.Clin Pharmacokinet. 2013 Nov;52(11):927-66. doi: 10.1007/s40262-013-0087-0. Clin Pharmacokinet. 2013. PMID: 23784470 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources